BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22285902)

  • 1. Role of PD-L1/PD-1 in the immune response to respiratory viral infections.
    Zdrenghea MT; Johnston SL
    Microbes Infect; 2012 Jun; 14(6):495-9. PubMed ID: 22285902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral acute lower respiratory infections impair CD8+ T cells through PD-1.
    Erickson JJ; Gilchuk P; Hastings AK; Tollefson SJ; Johnson M; Downing MB; Boyd KL; Johnson JE; Kim AS; Joyce S; Williams JV
    J Clin Invest; 2012 Aug; 122(8):2967-82. PubMed ID: 22797302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-1 signaling in neonates restrains CD8
    Eddens T; Parks OB; Zhang Y; Manni ML; Casanova JL; Ogishi M; Williams JV
    Mucosal Immunol; 2024 Jun; 17(3):476-490. PubMed ID: 38176655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection.
    Erickson JJ; Rogers MC; Hastings AK; Tollefson SJ; Williams JV
    J Immunol; 2014 Nov; 193(10):5108-17. PubMed ID: 25339663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive glia promote development of CD103
    Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
    Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Inhibitory Pathways Contribute to Lung CD8+ T Cell Impairment and Protect against Immunopathology during Acute Viral Respiratory Infection.
    Erickson JJ; Rogers MC; Tollefson SJ; Boyd KL; Williams JV
    J Immunol; 2016 Jul; 197(1):233-43. PubMed ID: 27259857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial cells suppress postencephalitic CD8+ T lymphocytes through PD-L1.
    Schachtele SJ; Hu S; Sheng WS; Mutnal MB; Lokensgard JR
    Glia; 2014 Oct; 62(10):1582-94. PubMed ID: 24890099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity.
    Telcian AG; Laza-Stanca V; Edwards MR; Harker JA; Wang H; Bartlett NW; Mallia P; Zdrenghea MT; Kebadze T; Coyle AJ; Openshaw PJ; Stanciu LA; Johnston SL
    J Infect Dis; 2011 Jan; 203(1):85-94. PubMed ID: 21148500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Viral Respiratory Infection Rapidly Induces a CD8+ T Cell Exhaustion-like Phenotype.
    Erickson JJ; Lu P; Wen S; Hastings AK; Gilchuk P; Joyce S; Shyr Y; Williams JV
    J Immunol; 2015 Nov; 195(9):4319-30. PubMed ID: 26401005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
    Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
    J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8
    Eissa IR; Mukoyama N; Abdelmoneim M; Naoe Y; Matsumura S; Bustos-Villalobos I; Ichinose T; Miyajima N; Morimoto D; Tanaka M; Fujimoto Y; Sone M; Kodera Y; Kasuya H
    Int J Cancer; 2021 Jul; 149(1):214-227. PubMed ID: 33687756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection.
    Yao S; Jiang L; Moser EK; Jewett LB; Wright J; Du J; Zhou B; Davis SD; Krupp NL; Braciale TJ; Sun J
    Mucosal Immunol; 2015 Jul; 8(4):746-59. PubMed ID: 25465101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal Cell PD-L1 Inhibits CD8
    O'Malley G; Treacy O; Lynch K; Naicker SD; Leonard NA; Lohan P; Dunne PD; Ritter T; Egan LJ; Ryan AE
    Cancer Immunol Res; 2018 Nov; 6(11):1426-1441. PubMed ID: 30228206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.
    Afroj T; Mitsuhashi A; Ogino H; Saijo A; Otsuka K; Yoneda H; Tobiume M; Nguyen NT; Goto H; Koyama K; Sugimoto M; Kondoh O; Nokihara H; Nishioka Y
    J Immunol; 2021 Mar; 206(6):1204-1214. PubMed ID: 33504617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pulmonary localization of virus-specific T lymphocytes is governed by the tissue tropism of infection.
    Knudson CJ; Weiss KA; Hartwig SM; Varga SM
    J Virol; 2014 Aug; 88(16):9010-6. PubMed ID: 24899187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion.
    Hofmeyer KA; Jeon H; Zang X
    J Biomed Biotechnol; 2011; 2011():451694. PubMed ID: 21960736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A missing PD-L1/PD-1 coinhibition regulates diabetes induction by preproinsulin-specific CD8 T-cells in an epitope-specific manner.
    Schuster C; Brosi H; Stifter K; Boehm BO; Schirmbeck R
    PLoS One; 2013; 8(8):e71746. PubMed ID: 23977133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.
    Tzeng HT; Tsai HF; Liao HJ; Lin YJ; Chen L; Chen PJ; Hsu PN
    PLoS One; 2012; 7(6):e39179. PubMed ID: 22761734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8
    David P; Megger DA; Kaiser T; Werner T; Liu J; Chen L; Sitek B; Dittmer U; Zelinskyy G
    Front Immunol; 2019; 10():54. PubMed ID: 30804928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
    Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
    Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.